Table 3 Correlation of TILs with other pathological features in HER2+ cases receiving neoadjuvant chemotherapy.

From: Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer

Indicators

Cases

M(QR)*

TILs

rs

P

Age

264

51(15)

− 0.025

0.687

ER (H-score)

264

1(140)

− 0.087

0.159

PR (H-score)

264

0(10)

− 0.019

0.756

Ki67 index (%)

255

40(30)

0.106

0.092

 P53

261

10(60)

0.084

0.176

 CK5/6

258

0(0)

0.101

0.105

 EGFR

258

0(30)

0.023

0.713

 AR (H-score)

256

120(130)

0.033

0.595

  1. M(QR)*: Expressed by median (interquartile range).
Back to article page